Quest Diagnostics delivered a Q4 performance that exceeded Wall Street’s revenue and earnings expectations, prompting a positive market reaction. Management attributed this outcome to strong organic ...

Shares of healthcare diagnostics company Quest Diagnostics (NYSE:DGX) jumped 6.8% in the afternoon session after the company reported strong fourth-quarter financial results and offered an upbeat ...

Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.35. Anticipation surrounds Quest ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Shares of Quest Diagnostics (DGX) reached a new 52-week high on Tuesday after the diagnostic services provider exceeded Street forecasts with its Q4 2025 financials and set its 2026 outlook above the ...

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript February 10, 2026 Quest Diagnostics Incorporated ...

Quest Diagnostics DGX is set to release fourth-quarter 2025 results on Feb. 10, before the market opens. The renowned ...

Quest Diagnostics is a dominant player in the growing medical testing industry, offering consistent earnings and dividend growth with lower volatility. DGX benefits from secular tailwinds like aging ...

The Quest Diagnostics patient service center at 1 Randall Square reopened last week following renovations. Quest leaders ...

Quest Diagnostics (NYSE: DGX) reported fourth quarter EPS of $2.42, $0.06 better than the analyst estimate of $2.36. Revenue for the quarter came in at $2.81B vers ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...